Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

Conditions:   Carcinoma, Squamous Cell;   Oral Cancer;   Oropharynx Cancer;   Larynx Cancer;   Lip Cancer;   Esophageal Cancer
Interventions:   Drug: Durvalumab;   Drug: Carboplatin;   Drug: Nab-paclitaxel;   Drug: Cisplatin;   Procedure: Surgical resection;   Radiation: IMRT
Sponsors:   UNC Lineberger Comprehensive Cancer Center;   AstraZeneca;   Celgene
Not yet recruiting - verified May 2017

http://ift.tt/2qHG2MQ